khoji parkDiscovery · London and Oxford · 1928
The Mould That Wasn’t Just a Mess
A contaminated culture plate offered a clue. Making it useful took much more than luck.
Read in slides1. Something on the plate
In 1928, Alexander Fleming observed a mould contaminating a bacterial culture at St Mary’s Hospital in London. Around it, the bacterial colonies looked different: they were breaking down. A contaminated experiment could have been dismissed as spoiled work. Fleming instead treated the unusual area as something to investigate.
The apparent mistake was the most interesting part of the plate.
2. A result that needed explaining
The observation in Fleming's laboratory did not arrive with instructions for producing a medicine. The growth pattern was a clue about an interaction between organisms. Establishing its significance required noticing the effect, investigating it and distinguishing what the evidence showed from what a future treatment would still need.
The useful part began with a question.
3. Following the clear space
Fleming isolated the mould and examined its properties. It belonged to the Penicillium group, and the antibacterial substance became known as penicillin. The important step was not simply noticing mould. It was connecting an observation to a testable effect on bacteria and pursuing the explanation.
An empty-looking patch was turning into a scientific lead.
4. A discovery is not a medicine
The observation did not immediately provide purified penicillin in useful amounts. Knowing that a substance can affect bacteria is different from making a dependable treatment. The gap between an interesting culture plate and a usable drug required further research, techniques and sustained work by other scientists.
The clue was promising. The medicine was not ready.
5. The team after the moment
Howard Florey, Ernst Chain and colleagues later investigated penicillin systematically. Their Oxford work helped turn Fleming’s finding into material that could be produced and studied more effectively. A story often remembered as one man’s accident depended on a much larger scientific effort to become useful.
Luck had opened a door. A team still had to build the corridor.
6. Three names on the award
The 1945 Nobel Prize in Physiology or Medicine was awarded jointly to Fleming, Chain and Florey. That shared award reflects an essential distinction: the original discovery and its development into a treatment were connected achievements. Compressing the whole history into a single lucky morning leaves out much of the work.
Even the prize came with more than one name.
7. Between a discovery and a dose
A substance that works in an experiment must still be prepared in a form patients can receive. Production, purity and testing therefore mattered alongside the original observation. The later medical achievement depended on that continuing work, which is easily lost when the story is reduced to one untidy dish.
A laboratory surprise still needed a supply chain.
8. The real surprise
Fleming’s Nobel lecture returned to the contaminated plate and the observations that followed. Its value was not that every messy experiment must hide a breakthrough. It was that an unexpected result became a question worth testing, and later researchers carried that question far beyond the original laboratory.
The breakthrough began with a mess. It survived because someone investigated.